Paper53661
Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation.
Allison AC and 3 others. Lancet, 1975. Cited by 144 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Papers, record 53661. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53661
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunologic Deficiency Syndromes | Major topic |
| Lesch-Nyhan Syndrome | Major topic |
| Lymphocyte Activation | Major topic |
| Purines | Major topic |
| Adenosine Deaminase | |
| Adolescent | |
| Azaserine | |
| B-Lymphocytes | |
| Child | |
| Child, Preschool | |
| Hemagglutinins | |
| Humans | |
| Hypersensitivity, Delayed | |
| Hypoxanthine Phosphoribosyltransferase | |
| Immunoglobulins | |
| In Vitro Techniques | |
| Lectins | |
| Lymphocytes | |
| Male | |
| Mercaptopurine | |
| Mitogens | |
| T-Lymphocytes | |
| Thymidine |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,710,358 | Gene Expression Analysis of HPRT-Deficient Cells Maintained with Physiological Levels of Folic Acid. | Cells | 2025 | https://conductscience.org/library/papers/40710358 | PubMed |
| 39,235,719 | Impact of Drug Conjugation Site and Corona Chemistry on the Therapeutic Activity of Polymer Nanorod - Drug Conjugates. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/39235719 | PubMed |
| 37,628,755 | Purine Nucleotide Alterations in Tumoral Cell Lines Maintained with Physiological Levels of Folic Acid. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628755 | PubMed |
| 37,338,709 | Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity. | Clin Rev Allergy Immunol | 2023 | https://conductscience.org/library/papers/37338709 | PubMed |
| 36,274,161 | Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma. | Acta Neuropathol Commun | 2022 | https://conductscience.org/library/papers/36274161 | PubMed |
| 35,690,417 | Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells. | Mutat Res Rev Mutat Res | 2022 | https://conductscience.org/library/papers/35690417 | PubMed |
| 34,245,829 | The molecular mechanisms of oxygen-sensing in human ductus arteriosus smooth muscle cells: A comprehensive transcriptome profile reveals a central role for mitochondria. | Genomics | 2021 | https://conductscience.org/library/papers/34245829 | PubMed |
| 28,322,861 | Pharmacological targeting of allergen-specific T lymphocytes. | Immunol Lett | 2017 | https://conductscience.org/library/papers/28322861 | PubMed |
| 24,162,612 | Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning. | Bone Marrow Transplant | 2014 | https://conductscience.org/library/papers/24162612 | PubMed |
| 21,935,470 | Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor. | PLoS One | 2011 | https://conductscience.org/library/papers/21935470 | PubMed |
| 21,398,490 | Molecular basis for mycophenolic acid biosynthesis in Penicillium brevicompactum. | Appl Environ Microbiol | 2011 | https://conductscience.org/library/papers/21398490 | PubMed |
| 20,052,390 | Mizoribine: a new approach in the treatment of renal disease. | Clin Dev Immunol | 2009 | https://conductscience.org/library/papers/20052390 | PubMed |
| 19,497,072 | Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. | Transpl Infect Dis | 2009 | https://conductscience.org/library/papers/19497072 | PubMed |
| 16,296,869 | Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis. | Drugs | 2005 | https://conductscience.org/library/papers/16296869 | PubMed |
| 15,126,382 | Two lessons from the interface of genetics and medicine. | Genetics | 2004 | https://conductscience.org/library/papers/15126382 | PubMed |
| 11,522,119 | Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. | Drug Saf | 2001 | https://conductscience.org/library/papers/11522119 | PubMed |
| 8,873,440 | The role of mycophenolate mofetil in clinical renal transplantation. | World J Urol | 1996 | https://conductscience.org/library/papers/8873440 | PubMed |
| 8,522,326 | Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs at the level of multipotent stem cells. | Hum Genet | 1995 | https://conductscience.org/library/papers/8522326 | PubMed |
| 8,322,167 | The design and development of an immunosuppressive drug, mycophenolate mofetil. | Springer Semin Immunopathol | 1993 | https://conductscience.org/library/papers/8322167 | PubMed |
| 7,679,843 | Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. | Transplant Proc | 1993 | https://conductscience.org/library/papers/7679843 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADA | 100 | PubTator's text mining | https://conductscience.org/library/genes/100 | NCBI Gene |
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
| HPRT1 | 3,251 | PubTator's text mining | https://conductscience.org/library/genes/3251 | NCBI Gene |
| IGHE | 3,497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/53661
GET https://conductscience.org/api/papers/v1/53661/cited_by?page=2